RVMD - Revolution Medicines Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2025-08-06    (Delayed quote data   2025-06-27)
Last
 36.91		 Change
 ⇓ -0.57   (-1.52%)		 Volume
  26,439,074
Open
 37.52		 High
 38.00		 Low
 36.77
8EMA (Daily)
 38.68		 40EMA (Daily)
 39.36		 50EMA (Daily)
 39.35		 STO (Daily)
 26.342		 MACD Hist (Daily)
 -0.822
8EMA (Weekly)
 39.145		 40EMA (Weekly)
 40.57		 50EMA (Weekly)
 40.37		 STO (Weekly)
 71.448		 MACD Hist (Weekly)
 0.166
Company Profile
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com